Navigation Links
Novartis's Serelaxin Has the Potential to Fulfill the Most Pertinent Unmet Needs in Acute Heart Failure by Reducing the Rate of Patient Mortality and the Rate of Worsening Renal Function
Date:7/29/2013

BURLINGTON, Mass., July 29, 2013 /PRNewswire/ --  Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical trial data and thought leader opinion, Novartis's novel vasodilative therapy serelaxin has the potential to gain acceptance among cardiologists for the treatment of acute heart failure, given that it is predicted to reduce mortality and prevent worsening renal function. While cardiologists are most compelled by drugs that reduce patient mortality, the high price of novel acute heart failure treatments could offset cardiologist receptivity to such agents. Payers also indicate that they would only accommodate such high price premiums in the presence of substantial improvements in efficacy. Cardiorentis's ularitide is similarly predicted to reduce mortality as well as offer other improvements in efficacy and safety compared to current therapies.     

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

The DecisionBase 2013 report entitled Acute Heart Failure: Can the Novel Vasodilators Serelaxin and Ularitide Fulfill the Unmet Needs Highlighted by Cardiologists? also finds that U.S. cardiologists regard reductions in acute heart failure hospital readmissions as an equally pressing unmet need to reducing patient mortality. However, none of the current or emerging therapies are expected to address the issue of patient rehospitalization. Although serelaxin was associated with a non-significant increase in rehospitalization in patient trials, this agent still received the highest preference share when compared to ularitide and Scios/Johnson & Johnson's Natrecor in Decision Resources' target product profile simulator.

The findings also reveal that all of the emerging acute heart failure therapies are set to surp
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis
2. Inovio Pharmaceuticals Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence
3. Cosmetic Surgery Solicitors Warn of Potential Risks Posed by Dermal Fillers
4. Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
5. AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
6. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
7. Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients
8. Merrimack Pharmaceuticals Phase 1 Research Supports MM-121 Potential For Investigation As Combination With Chemotherapy In Patients With Advanced Solid Tumors
9. PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition
10. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
11. Mylan Specialty L.P. Announces Partnership with Baseball Teams Across Country to Raise Awareness of Potentially Life-Threatening Allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... PLAINFIELD, N.J. , May 4, 2015 PTC ... update and reported financial results for the first quarter ending ... a strong start this year. In our first full quarter ... access to Translarna, the first treatment for nonsense mutation Duchene ... nearly double the number on treatment since our last earnings ...
(Date:5/4/2015)... BEACH, Va. , May 4, 2015 /PRNewswire/ ... investment company focused on the lower middle market, ... Inc. ("BMS").  Founded in 1969 and based in ... provides a full range of radiation products for ... Fox Three partnered with Peninsula Capital Partners ("Peninsula"), ...
(Date:5/4/2015)... Former NASA scientist Tamim Hamid ... he discussed Theradome™, the first portable and wearable OTC ... shows firsthand how, via laser technology, Theradome™ offers individuals ... will not require surgery or medication.  ... of the hair follicle, which is where the stem ...
Breaking Medicine Technology:PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 9Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2
... Eli Lilly and Company (NYSE: LLY ) ... bold, new education reform, today announced the launch of ... Works seeks to raise and invest $18 million in ... to serve more students and accelerate education reform. Lilly ...
... Germany-based medical device manufacturer B. Braun Melsungen ... (B. Braun) announced today that the company succeeded in ... against Japan,s Terumo Corporation and its U.S. subsidiary Terumo ... On April 21, 2011, the U.S. District ...
Cached Medicine Technology:Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 3Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 4B. Braun Obtains Permanent Injunction 2
(Date:5/4/2015)... Every Friday afternoon at A Forever Recovery, a result-driven ... and staff gather in the common room to celebrate ... to gain encouragement and inspiration in their continuing effort ... those patients who have completed their recovery programs come ... share a bit about their journey with the audience. ...
(Date:5/4/2015)... Global Vision, the industry leader ... announced that it will showcase Proofware at the ... in Nashville Tennessee, May 04 and May 05. ... all-in-one we-based packaging inspection suite, giving enterprise-wide instant ... their brand copy and artwork. Proofware offers a ...
(Date:5/4/2015)... MO (PRWEB) May 04, 2015 Leonardo ... president and chief physician executive, and William C. Daniel, ... received and accepted personal invitations from the Secretary of ... Security Forum (NSF) at the Air War College, Maxwell ... to expose influential citizens to senior U.S. and international ...
(Date:5/4/2015)... 2015 Milton Hershey School® has named ... of the Year, recognizing his commitment to pediatric cancer ... sets for MHS students. , “Dr. Graves is a ... children are provided a top-notch education, a nurturing environment, ... said Pete Gurt ’85, president of MHS. “He is ...
(Date:5/4/2015)... McNeil & Company , a nationwide ... coverage for its Emergency Services Insurance Program ... and proactive risk management to the emergency services industry. ... providing our customers with unparalleled service and the best ... are excited to launch over 100 new enhancements that ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3
... edition Mustang at the New York, International Auto Show to raise money for ... ... G. Komen Race for the Cure - to $500 ... dedicated more than $95 million in, cash and in-kind contributions for breast cancer education ...
... Placing a "super-long coffee order,",a quirky trait ... a,difference for Children,s Hospital and Regional Medical Center., ... $1 to Children,s,Hospital for every Tully,s Coffee customer ... unique concoctions made up of seemingly,incongruous ingredients and ...
... BETHESDA, Md., March 18 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: ... Board of,Directors has unanimously approved a three-for-two split of ... per share, including its Class,B Common Stock. Stockholders of ... 2008 will receive one-half additional share of Common Stock ...
... March 18 W. Scott Harkonen,M.D., the former ... fraud and,felony Food, Drug and Cosmetic Act charges ... false and misleading information about the efficacy of,InterMune,s ... pulmonary fibrosis (IPF), the Justice Department announced,today., ...
... Statement Is Contrary to Widely Held American Values, ... and CEO, Religious,Coalition for Reproductive Choice, WASHINGTON, ... the national coalition of mainstream religious and,religiously affiliated ... reproductive healthcare and for women themselves in,the statement ...
... 18 Leading experts and,distinguished faculty in ... protocols and research to over 400 multi-disciplinary,clinicians ... Disorders,Professionals Symposium (iaedp(TM)) ( http://www.iaedp.com/ ) April ... in Orlando, Florida., "This year,s symposium ...
Cached Medicine News:Health News:Ford Launches 'Warriors in Pink' Mustang for '09, Doubles Contributions To Race For The Cure 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 3Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 2Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 2Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 4Health News:National Religious Coalition Deeply Concerned by HHS Secretary's Disregard for Women's Reproductive Health 2Health News:Eating Disorders Take Center Stage at iaedp(TM) 2008 Symposium in Orlando, Florida 2
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
Medicine Products: